Acne

Latest News


CME Content


The pathogenesis of acne is not entirely understood, but new insights may yield new therapeutic targets in the near future. As research into the pathogenesis of acne continues, the spectrum of available therapies will continue to expand.

Skin of color patients exhibit clinical and therapeutic nuances that affect acne management. Dermatologists should understand how these patients present, clinically; how to treat them safely; cultural factors; and their specific desired treatment endpoints.

Take your medicine

A new study suggests that 27% of acne patients don’t get all or even, perhaps, any of their doctor-recommended acne medications. These patients are more likely to get their medications when only one treatment is prescribed.

In addition to being one of the most prevalent and all-too-familiar skin conditions, acne is also one of the most common skin diseases for which patients have begun to seek alternative treatment therapies. learn more.

There is increasing interest in so-called alternative medicine. Both patients and practitioners are clearly interested in this domain and this is in striking contrast to the bright, shining edifice of evidence-based medicine.

Dermatologists should keep an eye out for acne in pre-adolescent children as young as one year because pimples may be a sign of serious medical problems, a leading dermatologist told a crowd at the Maui Derm 2015 conference this week.

Dermatology Times editorial advisor, Elaine Siegfried, M.D., talks with Peter Lio, M.D., assistant professor of clinical dermatology and pediatrics at Northwestern University’s Feinberg School of Medicine, and private practice, Dermatology and Aesthetics of Wicker Park, Wicker Park, Chicago, about his interest in alternative medicine and the legitimacy and usefulness of certain techniques and therapies.

The Food and Drug Administration has approved Onexton Gel (clindamycin phosphate and benzoyl peroxide 1.2 percent/3.75 percent, Valeant Pharmaceuticals) for the once-daily treatment of comedonal and inflammatory acne in patients 12 and older.

Treatments for acne scars are improving rapidly, although complete fixes remain impossible and repairs require long-term treatment planning and management, according to a speaker Friday at the 2014 Annual Meeting of the American Society for Dermatologic Surgery. Greg Goodman, M.D., of The Dermatology Institute of Victoria in Australia, offered attendees tips and takeaways for treating scars.

Therapeutics is one of the most significant challenges in pediatric dermatology. Children have been identified as “therapeutic orphans”, with few options that have FDA-approved pediatric indications. Access to new and novel treatments like biologics is especially limited. Supportive legislation, beginning with the Best Pharmaceuticals for Children Act (bpca.nichd.nih.gov), has marked the dawn of a new era.

Though it’s known that oral contraceptive pills (OCPs) and systemic antibiotics are both effective in managing acne, there’s been precious little research comparing the two therapies head-to-head - until now.